Teva Hit With Securities Class Action Over CEO Resignation
Jill Edison alleged the unexpected resignation of CEO Jeremy Levin — just days after the company denied he would resign — caused the company to lose $2.8 billion in market capitalization, according to the suit.
“Plaintiff and the class purchased Teva securities at artificially inflated...
Already a subscriber? Click here to login